Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor

Tumors are a serious threat to human health. The oncolytic virus is a kind of tumor killer virus which can infect and lyse cancer cells and spread through the tumor, while leaving normal cells largely unharmed. Mathematical models can help us to understand the tumor-virus dynamics and find better tr...

Full description

Bibliographic Details
Main Authors: Yongmei Su, Chen Jia, Ying Chen
Format: Article
Language:English
Published: Hindawi Limited 2016-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2016/5621313
id doaj-a0c27504f6a1442f9c8ff803e6dbf5c8
record_format Article
spelling doaj-a0c27504f6a1442f9c8ff803e6dbf5c82020-11-24T20:55:22ZengHindawi LimitedBioMed Research International2314-61332314-61412016-01-01201610.1155/2016/56213135621313Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK InhibitorYongmei Su0Chen Jia1Ying Chen2School of Mathematics and Physics, University of Science and Technology Beijing, Beijing, ChinaSchool of Mathematics and Physics, University of Science and Technology Beijing, Beijing, ChinaSchool of Mathematics and Physics, University of Science and Technology Beijing, Beijing, ChinaTumors are a serious threat to human health. The oncolytic virus is a kind of tumor killer virus which can infect and lyse cancer cells and spread through the tumor, while leaving normal cells largely unharmed. Mathematical models can help us to understand the tumor-virus dynamics and find better treatment strategies. This paper gives a new mathematical model of tumor therapy with oncolytic virus and MEK inhibitor. Stable analysis was given. Because mitogen-activated protein kinase (MEK) can not only lead to greater oncolytic virus infection into cancer cells, but also limit the replication of the virus, in order to provide the best dosage of MEK inhibitors and balance the positive and negative effect of the inhibitors, we put forward an optimal control problem of the inhibitor. The optimal strategies are given by theory and simulation.http://dx.doi.org/10.1155/2016/5621313
collection DOAJ
language English
format Article
sources DOAJ
author Yongmei Su
Chen Jia
Ying Chen
spellingShingle Yongmei Su
Chen Jia
Ying Chen
Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor
BioMed Research International
author_facet Yongmei Su
Chen Jia
Ying Chen
author_sort Yongmei Su
title Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor
title_short Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor
title_full Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor
title_fullStr Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor
title_full_unstemmed Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor
title_sort optimal control model of tumor treatment with oncolytic virus and mek inhibitor
publisher Hindawi Limited
series BioMed Research International
issn 2314-6133
2314-6141
publishDate 2016-01-01
description Tumors are a serious threat to human health. The oncolytic virus is a kind of tumor killer virus which can infect and lyse cancer cells and spread through the tumor, while leaving normal cells largely unharmed. Mathematical models can help us to understand the tumor-virus dynamics and find better treatment strategies. This paper gives a new mathematical model of tumor therapy with oncolytic virus and MEK inhibitor. Stable analysis was given. Because mitogen-activated protein kinase (MEK) can not only lead to greater oncolytic virus infection into cancer cells, but also limit the replication of the virus, in order to provide the best dosage of MEK inhibitors and balance the positive and negative effect of the inhibitors, we put forward an optimal control problem of the inhibitor. The optimal strategies are given by theory and simulation.
url http://dx.doi.org/10.1155/2016/5621313
work_keys_str_mv AT yongmeisu optimalcontrolmodeloftumortreatmentwithoncolyticvirusandmekinhibitor
AT chenjia optimalcontrolmodeloftumortreatmentwithoncolyticvirusandmekinhibitor
AT yingchen optimalcontrolmodeloftumortreatmentwithoncolyticvirusandmekinhibitor
_version_ 1716791549613834240